(Q43276805)

18 November 2017

Erythromycin for prokinesis: imprudent prescribing? (English)

1 reference

18 November 2017

1 reference

Martino Dall'Antonia

1

1 reference

18 November 2017

Mark Wilks

2

1 reference

18 November 2017

Pietro G Coen

3

1 reference

18 November 2017

Susan Bragman

4

1 reference

18 November 2017

Michael R Millar

5

1 reference

18 November 2017

1 February 2006

1 reference

18 November 2017

1 reference

18 November 2017

10

1 reference

18 November 2017

1

1 reference

18 November 2017

112

1 reference

Minimising antibiotic resistance

18 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550835

Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550835

Prokinetic agents in critical care

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550835

Gastrointestinal promotility drugs in the critical care setting: a systematic review of the evidence

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550835

Antimicrobial use and antimicrobial resistance: a population perspective

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550835

In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550835

Antimicrobial susceptibility of polymerase chain reaction ribotypes of Clostridium difficile commonly isolated from symptomatic hospital patients in the UK.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550835

Competition between methicillin-sensitive and -resistant Staphylococcus aureus in the anterior nares

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550835

What comes after macrolides and other motilin stimulants?

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550835

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16420656

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Transfer of macrolide-lincosamide-streptogramin B (MLS) resistance in Clostridium difficile is linked to a gene homologous with toxin A and is mediated by a conjugative transposon, Tn5398

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16420656

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/CC3956

1 reference

Dimensions Publication ID

18 November 2017

0 references

1 reference

18 November 2017

PubMed publication ID

16420656

1 reference